nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP1A2—Omeprazole—Barrett's esophagus	0.16	0.242	CbGbCtD
Ondansetron—CYP2C9—Omeprazole—Barrett's esophagus	0.144	0.218	CbGbCtD
Ondansetron—CYP3A4—Esomeprazole—Barrett's esophagus	0.142	0.215	CbGbCtD
Ondansetron—CYP2D6—Omeprazole—Barrett's esophagus	0.132	0.199	CbGbCtD
Ondansetron—CYP3A4—Omeprazole—Barrett's esophagus	0.0837	0.127	CbGbCtD
Ondansetron—Anorectal discomfort—Esomeprazole—Barrett's esophagus	0.00763	0.0244	CcSEcCtD
Ondansetron—Anorectal discomfort—Omeprazole—Barrett's esophagus	0.00763	0.0244	CcSEcCtD
Ondansetron—Sleep disturbance—Esomeprazole—Barrett's esophagus	0.00744	0.0238	CcSEcCtD
Ondansetron—Sleep disturbance—Omeprazole—Barrett's esophagus	0.00744	0.0238	CcSEcCtD
Ondansetron—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.00735	0.0235	CcSEcCtD
Ondansetron—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.00735	0.0235	CcSEcCtD
Ondansetron—Laryngeal oedema—Esomeprazole—Barrett's esophagus	0.0065	0.0208	CcSEcCtD
Ondansetron—Laryngeal oedema—Omeprazole—Barrett's esophagus	0.0065	0.0208	CcSEcCtD
Ondansetron—Liver disorder—Omeprazole—Barrett's esophagus	0.00612	0.0196	CcSEcCtD
Ondansetron—Liver disorder—Esomeprazole—Barrett's esophagus	0.00612	0.0196	CcSEcCtD
Ondansetron—Hiccups—Esomeprazole—Barrett's esophagus	0.00417	0.0134	CcSEcCtD
Ondansetron—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00417	0.0134	CcSEcCtD
Ondansetron—Hiccups—Omeprazole—Barrett's esophagus	0.00417	0.0134	CcSEcCtD
Ondansetron—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00417	0.0134	CcSEcCtD
Ondansetron—Injection site reaction—Omeprazole—Barrett's esophagus	0.00415	0.0133	CcSEcCtD
Ondansetron—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00415	0.0133	CcSEcCtD
Ondansetron—Sleep disorder—Omeprazole—Barrett's esophagus	0.0035	0.0112	CcSEcCtD
Ondansetron—Sleep disorder—Esomeprazole—Barrett's esophagus	0.0035	0.0112	CcSEcCtD
Ondansetron—Swelling—Omeprazole—Barrett's esophagus	0.00343	0.011	CcSEcCtD
Ondansetron—Swelling—Esomeprazole—Barrett's esophagus	0.00343	0.011	CcSEcCtD
Ondansetron—Hepatic failure—Omeprazole—Barrett's esophagus	0.00337	0.0108	CcSEcCtD
Ondansetron—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00337	0.0108	CcSEcCtD
Ondansetron—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00319	0.0102	CcSEcCtD
Ondansetron—Visual disturbance—Omeprazole—Barrett's esophagus	0.00319	0.0102	CcSEcCtD
Ondansetron—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00275	0.00883	CcSEcCtD
Ondansetron—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00275	0.00883	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00273	0.00874	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00273	0.00874	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00273	0.00874	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00273	0.00874	CcSEcCtD
Ondansetron—Asthma—Omeprazole—Barrett's esophagus	0.00262	0.00838	CcSEcCtD
Ondansetron—Asthma—Esomeprazole—Barrett's esophagus	0.00262	0.00838	CcSEcCtD
Ondansetron—Bronchospasm—Omeprazole—Barrett's esophagus	0.00257	0.00825	CcSEcCtD
Ondansetron—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00257	0.00825	CcSEcCtD
Ondansetron—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00255	0.00817	CcSEcCtD
Ondansetron—Angina pectoris—Omeprazole—Barrett's esophagus	0.00255	0.00817	CcSEcCtD
Ondansetron—Dysuria—Esomeprazole—Barrett's esophagus	0.00245	0.00784	CcSEcCtD
Ondansetron—Dysuria—Omeprazole—Barrett's esophagus	0.00245	0.00784	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00231	0.00741	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00231	0.00741	CcSEcCtD
Ondansetron—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00227	0.00727	CcSEcCtD
Ondansetron—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00227	0.00727	CcSEcCtD
Ondansetron—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00221	0.00707	CcSEcCtD
Ondansetron—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00221	0.00707	CcSEcCtD
Ondansetron—Bradycardia—Omeprazole—Barrett's esophagus	0.00213	0.00683	CcSEcCtD
Ondansetron—Bradycardia—Esomeprazole—Barrett's esophagus	0.00213	0.00683	CcSEcCtD
Ondansetron—Visual impairment—Esomeprazole—Barrett's esophagus	0.00202	0.00647	CcSEcCtD
Ondansetron—Visual impairment—Omeprazole—Barrett's esophagus	0.00202	0.00647	CcSEcCtD
Ondansetron—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00198	0.00634	CcSEcCtD
Ondansetron—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00198	0.00634	CcSEcCtD
Ondansetron—Eye disorder—Esomeprazole—Barrett's esophagus	0.00196	0.00627	CcSEcCtD
Ondansetron—Eye disorder—Omeprazole—Barrett's esophagus	0.00196	0.00627	CcSEcCtD
Ondansetron—Flushing—Omeprazole—Barrett's esophagus	0.00194	0.00623	CcSEcCtD
Ondansetron—Flushing—Esomeprazole—Barrett's esophagus	0.00194	0.00623	CcSEcCtD
Ondansetron—Immune system disorder—Omeprazole—Barrett's esophagus	0.00189	0.00606	CcSEcCtD
Ondansetron—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00189	0.00606	CcSEcCtD
Ondansetron—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00189	0.00605	CcSEcCtD
Ondansetron—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00189	0.00605	CcSEcCtD
Ondansetron—Chills—Esomeprazole—Barrett's esophagus	0.00188	0.00602	CcSEcCtD
Ondansetron—Chills—Omeprazole—Barrett's esophagus	0.00188	0.00602	CcSEcCtD
Ondansetron—Flatulence—Esomeprazole—Barrett's esophagus	0.0018	0.00576	CcSEcCtD
Ondansetron—Flatulence—Omeprazole—Barrett's esophagus	0.0018	0.00576	CcSEcCtD
Ondansetron—Vision blurred—Esomeprazole—Barrett's esophagus	0.00172	0.00551	CcSEcCtD
Ondansetron—Vision blurred—Omeprazole—Barrett's esophagus	0.00172	0.00551	CcSEcCtD
Ondansetron—Tremor—Esomeprazole—Barrett's esophagus	0.00171	0.00547	CcSEcCtD
Ondansetron—Tremor—Omeprazole—Barrett's esophagus	0.00171	0.00547	CcSEcCtD
Ondansetron—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00169	0.00542	CcSEcCtD
Ondansetron—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00169	0.00542	CcSEcCtD
Ondansetron—Agitation—Omeprazole—Barrett's esophagus	0.00168	0.00537	CcSEcCtD
Ondansetron—Agitation—Esomeprazole—Barrett's esophagus	0.00168	0.00537	CcSEcCtD
Ondansetron—Angioedema—Omeprazole—Barrett's esophagus	0.00167	0.00534	CcSEcCtD
Ondansetron—Angioedema—Esomeprazole—Barrett's esophagus	0.00167	0.00534	CcSEcCtD
Ondansetron—Malaise—Esomeprazole—Barrett's esophagus	0.00164	0.00527	CcSEcCtD
Ondansetron—Malaise—Omeprazole—Barrett's esophagus	0.00164	0.00527	CcSEcCtD
Ondansetron—Palpitations—Esomeprazole—Barrett's esophagus	0.00161	0.00516	CcSEcCtD
Ondansetron—Palpitations—Omeprazole—Barrett's esophagus	0.00161	0.00516	CcSEcCtD
Ondansetron—Cough—Omeprazole—Barrett's esophagus	0.00159	0.0051	CcSEcCtD
Ondansetron—Cough—Esomeprazole—Barrett's esophagus	0.00159	0.0051	CcSEcCtD
Ondansetron—Chest pain—Omeprazole—Barrett's esophagus	0.00155	0.00497	CcSEcCtD
Ondansetron—Chest pain—Esomeprazole—Barrett's esophagus	0.00155	0.00497	CcSEcCtD
Ondansetron—Anxiety—Omeprazole—Barrett's esophagus	0.00155	0.00496	CcSEcCtD
Ondansetron—Anxiety—Esomeprazole—Barrett's esophagus	0.00155	0.00496	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00154	0.00494	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00154	0.00494	CcSEcCtD
Ondansetron—Discomfort—Esomeprazole—Barrett's esophagus	0.00153	0.00491	CcSEcCtD
Ondansetron—Discomfort—Omeprazole—Barrett's esophagus	0.00153	0.00491	CcSEcCtD
Ondansetron—Dry mouth—Esomeprazole—Barrett's esophagus	0.00152	0.00486	CcSEcCtD
Ondansetron—Dry mouth—Omeprazole—Barrett's esophagus	0.00152	0.00486	CcSEcCtD
Ondansetron—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00149	0.00477	CcSEcCtD
Ondansetron—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00149	0.00477	CcSEcCtD
Ondansetron—Shock—Omeprazole—Barrett's esophagus	0.00146	0.00469	CcSEcCtD
Ondansetron—Shock—Esomeprazole—Barrett's esophagus	0.00146	0.00469	CcSEcCtD
Ondansetron—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00146	0.00468	CcSEcCtD
Ondansetron—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00146	0.00468	CcSEcCtD
Ondansetron—Tachycardia—Omeprazole—Barrett's esophagus	0.00145	0.00465	CcSEcCtD
Ondansetron—Tachycardia—Esomeprazole—Barrett's esophagus	0.00145	0.00465	CcSEcCtD
Ondansetron—Skin disorder—Esomeprazole—Barrett's esophagus	0.00145	0.00463	CcSEcCtD
Ondansetron—Skin disorder—Omeprazole—Barrett's esophagus	0.00145	0.00463	CcSEcCtD
Ondansetron—Paraesthesia—Omeprazole—Barrett's esophagus	0.00134	0.00428	CcSEcCtD
Ondansetron—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00134	0.00428	CcSEcCtD
Ondansetron—Dyspnoea—Omeprazole—Barrett's esophagus	0.00133	0.00425	CcSEcCtD
Ondansetron—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00133	0.00425	CcSEcCtD
Ondansetron—Somnolence—Omeprazole—Barrett's esophagus	0.00132	0.00424	CcSEcCtD
Ondansetron—Somnolence—Esomeprazole—Barrett's esophagus	0.00132	0.00424	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00412	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00128	0.00412	CcSEcCtD
Ondansetron—Fatigue—Omeprazole—Barrett's esophagus	0.00128	0.00411	CcSEcCtD
Ondansetron—Fatigue—Esomeprazole—Barrett's esophagus	0.00128	0.00411	CcSEcCtD
Ondansetron—Constipation—Esomeprazole—Barrett's esophagus	0.00127	0.00408	CcSEcCtD
Ondansetron—Pain—Esomeprazole—Barrett's esophagus	0.00127	0.00408	CcSEcCtD
Ondansetron—Constipation—Omeprazole—Barrett's esophagus	0.00127	0.00408	CcSEcCtD
Ondansetron—Pain—Omeprazole—Barrett's esophagus	0.00127	0.00408	CcSEcCtD
Ondansetron—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00123	0.00393	CcSEcCtD
Ondansetron—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00123	0.00393	CcSEcCtD
Ondansetron—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00122	0.0039	CcSEcCtD
Ondansetron—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00122	0.0039	CcSEcCtD
Ondansetron—Urticaria—Esomeprazole—Barrett's esophagus	0.00118	0.00379	CcSEcCtD
Ondansetron—Urticaria—Omeprazole—Barrett's esophagus	0.00118	0.00379	CcSEcCtD
Ondansetron—Body temperature increased—Omeprazole—Barrett's esophagus	0.00118	0.00377	CcSEcCtD
Ondansetron—Abdominal pain—Omeprazole—Barrett's esophagus	0.00118	0.00377	CcSEcCtD
Ondansetron—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00118	0.00377	CcSEcCtD
Ondansetron—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00118	0.00377	CcSEcCtD
Ondansetron—Hypersensitivity—Omeprazole—Barrett's esophagus	0.0011	0.00351	CcSEcCtD
Ondansetron—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.0011	0.00351	CcSEcCtD
Ondansetron—Asthenia—Esomeprazole—Barrett's esophagus	0.00107	0.00342	CcSEcCtD
Ondansetron—Asthenia—Omeprazole—Barrett's esophagus	0.00107	0.00342	CcSEcCtD
Ondansetron—Pruritus—Esomeprazole—Barrett's esophagus	0.00105	0.00337	CcSEcCtD
Ondansetron—Pruritus—Omeprazole—Barrett's esophagus	0.00105	0.00337	CcSEcCtD
Ondansetron—Diarrhoea—Omeprazole—Barrett's esophagus	0.00102	0.00326	CcSEcCtD
Ondansetron—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00102	0.00326	CcSEcCtD
Ondansetron—Dizziness—Esomeprazole—Barrett's esophagus	0.000984	0.00315	CcSEcCtD
Ondansetron—Dizziness—Omeprazole—Barrett's esophagus	0.000984	0.00315	CcSEcCtD
Ondansetron—Vomiting—Esomeprazole—Barrett's esophagus	0.000946	0.00303	CcSEcCtD
Ondansetron—Vomiting—Omeprazole—Barrett's esophagus	0.000946	0.00303	CcSEcCtD
Ondansetron—Rash—Omeprazole—Barrett's esophagus	0.000938	0.00301	CcSEcCtD
Ondansetron—Rash—Esomeprazole—Barrett's esophagus	0.000938	0.00301	CcSEcCtD
Ondansetron—Dermatitis—Omeprazole—Barrett's esophagus	0.000937	0.003	CcSEcCtD
Ondansetron—Dermatitis—Esomeprazole—Barrett's esophagus	0.000937	0.003	CcSEcCtD
Ondansetron—Headache—Esomeprazole—Barrett's esophagus	0.000932	0.00299	CcSEcCtD
Ondansetron—Headache—Omeprazole—Barrett's esophagus	0.000932	0.00299	CcSEcCtD
Ondansetron—HTR3A—Ion channel transport—ATP4A—Barrett's esophagus	0.00072	0.0269	CbGpPWpGaD
Ondansetron—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00067	0.0251	CbGpPWpGaD
Ondansetron—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00067	0.0251	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000619	0.0231	CbGpPWpGaD
Ondansetron—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000587	0.022	CbGpPWpGaD
Ondansetron—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000579	0.0217	CbGpPWpGaD
Ondansetron—CYP2E1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.000555	0.0208	CbGpPWpGaD
Ondansetron—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000541	0.0202	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000513	0.0192	CbGpPWpGaD
Ondansetron—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000476	0.0178	CbGpPWpGaD
Ondansetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000471	0.0176	CbGpPWpGaD
Ondansetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000471	0.0176	CbGpPWpGaD
Ondansetron—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000463	0.0173	CbGpPWpGaD
Ondansetron—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000457	0.0171	CbGpPWpGaD
Ondansetron—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000425	0.0159	CbGpPWpGaD
Ondansetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000424	0.0159	CbGpPWpGaD
Ondansetron—CYP2E1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00042	0.0157	CbGpPWpGaD
Ondansetron—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000419	0.0157	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000406	0.0152	CbGpPWpGaD
Ondansetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000403	0.0151	CbGpPWpGaD
Ondansetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000403	0.0151	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000399	0.0149	CbGpPWpGaD
Ondansetron—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00039	0.0146	CbGpPWpGaD
Ondansetron—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000345	0.0129	CbGpPWpGaD
Ondansetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000344	0.0129	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000331	0.0124	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000318	0.0119	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000314	0.0118	CbGpPWpGaD
Ondansetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000311	0.0116	CbGpPWpGaD
Ondansetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000311	0.0116	CbGpPWpGaD
Ondansetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000302	0.0113	CbGpPWpGaD
Ondansetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000299	0.0112	CbGpPWpGaD
Ondansetron—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000298	0.0111	CbGpPWpGaD
Ondansetron—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000295	0.011	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000282	0.0105	CbGpPWpGaD
Ondansetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000256	0.00956	CbGpPWpGaD
Ondansetron—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000253	0.00946	CbGpPWpGaD
Ondansetron—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000252	0.00944	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000251	0.00937	CbGpPWpGaD
Ondansetron—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000249	0.00933	CbGpPWpGaD
Ondansetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000245	0.00915	CbGpPWpGaD
Ondansetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000242	0.00907	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—SST—Barrett's esophagus	0.000242	0.00906	CbGpPWpGaD
Ondansetron—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00022	0.00824	CbGpPWpGaD
Ondansetron—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000215	0.00806	CbGpPWpGaD
Ondansetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000207	0.00775	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000203	0.00758	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—GAST—Barrett's esophagus	0.0002	0.00747	CbGpPWpGaD
Ondansetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000197	0.00738	CbGpPWpGaD
Ondansetron—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000195	0.00728	CbGpPWpGaD
Ondansetron—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000183	0.00685	CbGpPWpGaD
Ondansetron—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000183	0.00683	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—GAST—Barrett's esophagus	0.000181	0.00679	CbGpPWpGaD
Ondansetron—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000181	0.00675	CbGpPWpGaD
Ondansetron—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00018	0.00674	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000177	0.00661	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000175	0.00654	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—SST—Barrett's esophagus	0.000167	0.00625	CbGpPWpGaD
Ondansetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00016	0.00598	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000158	0.00592	CbGpPWpGaD
Ondansetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000155	0.0058	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000154	0.00574	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000148	0.00552	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—SST—Barrett's esophagus	0.000137	0.00512	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000133	0.00497	CbGpPWpGaD
Ondansetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000132	0.00496	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000131	0.00492	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.00013	0.00486	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000129	0.00482	CbGpPWpGaD
Ondansetron—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000128	0.00479	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—SST—Barrett's esophagus	0.000127	0.00476	CbGpPWpGaD
Ondansetron—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000127	0.00475	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—SST—Barrett's esophagus	0.000124	0.00465	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000124	0.00464	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000117	0.00439	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.00011	0.00412	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.00011	0.00411	CbGpPWpGaD
Ondansetron—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000109	0.00406	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GAST—Barrett's esophagus	0.000107	0.00401	CbGpPWpGaD
Ondansetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000102	0.00382	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000101	0.00379	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—SST—Barrett's esophagus	0.000101	0.00379	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—CXCL8—Barrett's esophagus	9.44e-05	0.00353	CbGpPWpGaD
Ondansetron—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.96e-05	0.00335	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—SST—Barrett's esophagus	8.93e-05	0.00334	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	8.49e-05	0.00318	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	8.42e-05	0.00315	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.38e-05	0.00313	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—GAST—Barrett's esophagus	8.35e-05	0.00312	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	8.18e-05	0.00306	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—SST—Barrett's esophagus	7.71e-05	0.00288	CbGpPWpGaD
Ondansetron—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.65e-05	0.00286	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—GAST—Barrett's esophagus	7.58e-05	0.00284	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—GAST—Barrett's esophagus	7.37e-05	0.00276	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SST—Barrett's esophagus	7.34e-05	0.00275	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	6.89e-05	0.00258	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	6.81e-05	0.00255	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—GAST—Barrett's esophagus	6.69e-05	0.0025	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.53e-05	0.00244	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.51e-05	0.00244	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—GAST—Barrett's esophagus	6.36e-05	0.00238	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GAST—Barrett's esophagus	5.77e-05	0.00216	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.75e-05	0.00215	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—SST—Barrett's esophagus	5.72e-05	0.00214	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.7e-05	0.00213	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.58e-05	0.00209	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.33e-05	0.002	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—SST—Barrett's esophagus	5.19e-05	0.00194	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.18e-05	0.00194	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—SST—Barrett's esophagus	5.05e-05	0.00189	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—CXCL8—Barrett's esophagus	4.96e-05	0.00186	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CXCL8—Barrett's esophagus	4.84e-05	0.00181	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—SST—Barrett's esophagus	4.58e-05	0.00171	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.57e-05	0.00171	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GAST—Barrett's esophagus	4.48e-05	0.00167	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—SST—Barrett's esophagus	4.36e-05	0.00163	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	4.32e-05	0.00162	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGES—Barrett's esophagus	4.13e-05	0.00155	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGES—Barrett's esophagus	4.12e-05	0.00154	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—SST—Barrett's esophagus	3.96e-05	0.00148	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GAST—Barrett's esophagus	3.95e-05	0.00148	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.94e-05	0.00148	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CXCL8—Barrett's esophagus	3.94e-05	0.00148	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—APC—Barrett's esophagus	3.89e-05	0.00145	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.48e-05	0.0013	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GAST—Barrett's esophagus	3.41e-05	0.00128	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	3.13e-05	0.00117	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.12e-05	0.00117	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	3.12e-05	0.00117	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SST—Barrett's esophagus	3.07e-05	0.00115	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RELA—Barrett's esophagus	3.04e-05	0.00114	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CXCL8—Barrett's esophagus	3e-05	0.00112	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.93e-05	0.0011	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.91e-05	0.00109	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CXCL8—Barrett's esophagus	2.86e-05	0.00107	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SST—Barrett's esophagus	2.71e-05	0.00101	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.48e-05	0.000929	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SST—Barrett's esophagus	2.34e-05	0.000874	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	2.26e-05	0.000844	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.25e-05	0.000843	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.23e-05	0.000834	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.22e-05	0.000831	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.2e-05	0.000824	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.02e-05	0.000757	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.97e-05	0.000736	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.92e-05	0.000717	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.88e-05	0.000704	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.79e-05	0.000668	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TP53—Barrett's esophagus	1.76e-05	0.000657	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.7e-05	0.000635	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.63e-05	0.000609	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APC—Barrett's esophagus	1.62e-05	0.000607	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.6e-05	0.000599	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.59e-05	0.000594	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.54e-05	0.000577	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.45e-05	0.000543	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APC—Barrett's esophagus	1.43e-05	0.000536	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.42e-05	0.000532	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.39e-05	0.00052	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.36e-05	0.000508	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.28e-05	0.000479	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RELA—Barrett's esophagus	1.27e-05	0.000475	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APC—Barrett's esophagus	1.24e-05	0.000463	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—Barrett's esophagus	1.2e-05	0.000447	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RELA—Barrett's esophagus	1.12e-05	0.000419	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.12e-05	0.000419	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.09e-05	0.000409	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—Barrett's esophagus	1.06e-05	0.000395	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.05e-05	0.000392	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—Barrett's esophagus	1.03e-05	0.000385	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.03e-05	0.000385	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RELA—Barrett's esophagus	9.66e-06	0.000362	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—Barrett's esophagus	9.11e-06	0.000341	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	8.1e-06	0.000303	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	8.09e-06	0.000303	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—Barrett's esophagus	7.34e-06	0.000274	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—Barrett's esophagus	7.31e-06	0.000273	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.25e-06	0.000271	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—Barrett's esophagus	6.47e-06	0.000242	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—Barrett's esophagus	6.19e-06	0.000232	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.75e-06	0.000215	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.7e-06	0.000213	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—Barrett's esophagus	5.59e-06	0.000209	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.87e-06	0.000182	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.78e-06	0.000179	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.76e-06	0.000141	CbGpPWpGaD
